Mabion S.A. (WSE:MAB)
Poland · Delayed Price · Currency is PLN 7.73
+0.02 (0.26%)
Nov 4, 2026, 1:44 PM CET
Mabion Market Cap
Mabion has a market cap or net worth of 124.93 million as of November 3, 2026. It is the 33,350th most valuable company in the world and the 239th biggest in Poland. Its market cap has decreased by 6.98% in one year.
Market Cap
124.93M
Enterprise Value
151.58M
Revenue
17.61M
Global Rank
Country Rank
#239 Poland
PE Ratio
n/a
ChartMarket Cap Chart
Since August 10, 2010, Mabion's market cap has increased from 93.01M to 124.93M, an increase of 34.32%. That is a compound annual growth rate of 1.83%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 2, 2026 | 127.68M | 13.18% |
| Dec 30, 2025 | 112.81M | -21.57% |
| Dec 30, 2024 | 143.84M | -50.96% |
| Dec 29, 2023 | 293.35M | -13.57% |
| Dec 30, 2022 | 339.41M | -65.63% |
| Dec 30, 2021 | 987.46M | 246.59% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ryvu Therapeutics | 392.58M |
| Bioceltix | 387.26M |
| Captor Therapeutics Spolka Akcyjna | 336.73M |
| BIOTON | 291.94M |
| Synthaverse | 200.69M |
| Poltreg | 126.02M |
| Molecure | 119.09M |
| NanoGroup | 100.18M |